ICU Medical, Inc. (NASDAQ:ICUI) Director Elisha W. Finney Sells 2,424 Shares of Stock

ICU Medical, Inc. (NASDAQ:ICUI) Director Elisha W. Finney sold 2,424 shares of the firm’s stock in a transaction dated Tuesday, September 14th. The shares were sold at an average price of $242.20, for a total transaction of $587,092.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

ICU Medical stock opened at $239.22 on Wednesday. The company’s 50 day simple moving average is $202.38 and its 200 day simple moving average is $204.47. ICU Medical, Inc. has a fifty-two week low of $176.18 and a fifty-two week high of $282.00. The firm has a market capitalization of $5.07 billion, a price-to-earnings ratio of 50.15 and a beta of 0.60.

ICU Medical (NASDAQ:ICUI) last released its quarterly earnings data on Wednesday, August 4th. The medical instruments supplier reported $1.57 earnings per share for the quarter, topping the consensus estimate of $1.43 by $0.14. ICU Medical had a net margin of 8.07% and a return on equity of 8.67%. The business had revenue of $321.68 million for the quarter, compared to analyst estimates of $306.30 million. As a group, research analysts anticipate that ICU Medical, Inc. will post 6.18 EPS for the current fiscal year.

A number of institutional investors have recently added to or reduced their stakes in ICUI. Advisory Services Network LLC bought a new position in ICU Medical in the second quarter valued at approximately $43,000. Van ECK Associates Corp lifted its stake in ICU Medical by 115.3% in the second quarter. Van ECK Associates Corp now owns 239 shares of the medical instruments supplier’s stock valued at $49,000 after buying an additional 128 shares in the last quarter. Quantbot Technologies LP bought a new position in ICU Medical in the first quarter valued at approximately $80,000. Acadian Asset Management LLC lifted its stake in ICU Medical by 91.6% in the first quarter. Acadian Asset Management LLC now owns 711 shares of the medical instruments supplier’s stock valued at $146,000 after buying an additional 340 shares in the last quarter. Finally, Huntington National Bank lifted its stake in ICU Medical by 54.9% in the second quarter. Huntington National Bank now owns 714 shares of the medical instruments supplier’s stock valued at $147,000 after buying an additional 253 shares in the last quarter. 94.93% of the stock is currently owned by institutional investors and hedge funds.

Several equities research analysts have recently commented on the stock. KeyCorp lifted their price target on shares of ICU Medical from $225.00 to $302.00 and gave the stock an “overweight” rating in a research report on Thursday, September 9th. Raymond James lifted their price target on shares of ICU Medical from $220.00 to $286.00 and gave the stock an “outperform” rating in a research report on Thursday, September 9th. Finally, Zacks Investment Research cut shares of ICU Medical from a “hold” rating to a “sell” rating in a research report on Wednesday, August 11th.

About ICU Medical

ICU Medical, Inc engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors.

Recommended Story: Understanding Market Liquidity

Insider Buying and Selling by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical and related companies with MarketBeat.com's FREE daily email newsletter.